Edukimi
10/03/2017-19/03/2021
Specializim Pasuniversitar n毛 deg毛n Onkologji pran毛 Fakultetit t毛 Mjek毛sis毛, Qendra Spitalore Universitare 鈥淣ene Tereza鈥 Tirana (Albania)
2005-2011
Diplomuar n毛 Fakultetin e Mjek毛sis毛 si Mjek i P毛rgjithsh毛m.
Eksperiencat e pun毛s
10/03/2017鈥19/03/2021
Specializim p毛r Onkologjin毛 Klinike Qendra Spitalore Universitare 鈥淣毛n毛 Tereza鈥 Tirana (Albania)
10/04/2018鈥01/07/2021
Mjeke Urgjence Spitali Amerikan 2
10/04/2016鈥10/04/2018
Asistente e Kirurgjis毛 Okologjike dhe t毛 P毛rgjithshme Spitali Amerikan 2
10/04/2015鈥10/04/2016
Mjeke Pavioni n毛 repartin e Kirurgjis毛 s毛 P毛rgjithshme dhe Neurokirurgjis毛 Spitali Amerikan 2
01/04/2013鈥01/04/2015
Mjeke Urgjence Spitali Amerikan 2 Asistente e Kirurgjis毛 Okologjike dhe t毛 P毛rgjithshme Spitali Amerikan 2 Mjeke Pavioni n毛 repartin e Kirurgjis毛 s毛 P毛rgjithshme dhe Neurokirurgjis毛 Spitali Amerikan 2 Koordinatore pran毛 repartit t毛 Radiologjis毛 Spitali Hygeia
Trajnime dhe konferenca
Visiting Professorship Meeting on Breast Cancer: A Continuing Challenge. ESO-Maj 2019
Konferenca Mjek毛sore Onkologji, fokus 鈥淩oli I MDT n毛 trajtimin e kancerit鈥-Shtator 2019
Satellite Symposia on Breast Cancer- Nentor 2018
Konferenca Mjek毛sore e Radiologjis毛 鈥淜anceri I gjirit-Perqasje multidisiplinare鈥- Shtator 2018
4-th International multidisciplinary Medical Congress 鈥揘entor 2018
Doping Control officer/Blood Collection Officer EERADO- Maj 2016
Perspectives on the Diagnosis and Management of Epithelioid Sarcoma- N毛ntor 2020
Immune Checkpoint Inhibitors in Advanced Endometrial Cancer: Latest Updates and Recommendations -N毛ntor 2020
Prostate Cancer Clinic: Multidisciplinary Team Approach to Oral Therapies- N毛ntor 2020
Current and Future Role of Immune Checkpoint Inhibitors for the Treatment of Advanced Bladder Cancer- N毛ntor 2020
Clinical Challenge: Managing Advanced and Metastatic RCC- Tetor 2020
Expert Insights on Emerging Data for the Use of Immunotherapy in Advanced RCC-Tetor 2020
The Path at Progression: Second-Line Treatment Options in Advanced HCC- Tetor 2020
The Rationale for PARP Inhibitors and Their Combination With Immunotherapy in Solid Tumors 鈥2020
Testing and Tailoring Therapy in Advanced Triple-Negative Breast Cancer-2020
Frontline Combination Therapies for EGFR-Mutated Metastatic NSCLC: Rationale and Future Prospects-2020
Case Challenges in The Management of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) – 2019
The New Frontier: Applying Emerging Data to the Treatment of Advanced HCC-2019
Adoption and Implementation of Evidence-Based Colorectal Cancer Screening Interventions Among Cancer Control Program Grantees, 2009-2015
Opportunities and Possibilities: Cancer Immunotherapy in the Management of GI Cancers-2019
Challenges and Opportunities in the Management of Advanced Gastric Cancer-2018
Optimizing Outcomes: Multidisciplinary Management of Advanced Bladder Cancer-2018
Optimizing Outcomes in the Management of GIST-2018
What are the Current ASCO庐 Guidelines for HER2 Positive Breast Cancer?-2018
Advancing Care Across the Spectrum of Pancreatic Cancer-2018
